Inês Martins, PhD, managing science editor —

While people with hypoparathyroidism receiving conventional treatment with supplements experience significant declines in kidney function over time, the replacement therapy Natpara appears to preserve kidney function in the long-term, a five-year analysis shows. The study, “5-Year Estimated Glomerular Filtration Rate in Patients with Hypoparathyroidism Treated…

People with hypoparathyroidism experience extensive changes in bone microstructure compared with the general population, a pilot study revealed. Such changes appear to be more prominent in patients whose disease has a cause other than surgery. Factors such as age, menstrual status in women, and treatment duration in men…

People with hypoparathyroidism whose disease cannot be sustainably controlled with conventional treatment and parathyroid hormone (PTH) infusions may benefit from a continuous PTH infusion using an insulin pump, a case series suggests. The approach was found to be safe and to control the disease for 5.5 years or…

People who undergo surgery to remove the entire thyroid gland have a much higher incidence of chronic hypoparathyrodism than previously reported, with younger patients and those with so-called toxic thyroid disease at particular risk, a study in Denmark found. The study, “High incidence of…

Although the COVID-19 pandemic is profoundly affecting daily life around the world, Takeda does not expect disruptions in the global supply of any of its products in the near future, the company said in a statement. Hypoparathyrodism patients in the U.S. receiving the parathyroid…